title: Interleukin-2 soon may receive FDA's green light.
authors.forename: C
authors.initials: C
authors.lastname: Marwick
mesh_terms: D006801:Humans; D007376:Interleukin-2; D007680:Kidney Neoplasms / Q000628:therapy; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007376:Interleukin-2